2026-05-31T21:56:14Zhttps://riubu.ubu.es/oai/request

oai:riubu.ubu.es:10259/116072026-05-15T11:45:27Zcom_10259_4219com_10259_5086com_10259_2604col_10259_4220

García Bustillo, Álvaro 889 600 0000-0003-2561-1003 Youn, Jinyoung 1b253c16-07f3-45b6-912d-36fc8a949e23 600 Ahn, Jong Hyeon 886152b5-d697-4020-be91-043d7319343b 600 Ojo, Oluwadamilola 2dece23e-cb14-4430-8d1d-95d6b055055e 600 Okubadejo, Njideka b4671bed-9371-4438-84c1-23df6d8341b3 600 Aldaajani, Zakiyah 33a5db40-c362-40db-904d-79266d9aa5ef 600 Essam, Mohamed a9a1e2f2-c852-414a-a4ac-b4326ce46fdb 600 Shalash, Ali b3b3e56b-5cf0-4889-8890-8f148f8bd5eb 600 Cardozo, Adriana 3cf2ec2b-95fc-42e8-a5c4-4d11fe5e413b 600 Spindler, Meredith 5b47fb0e-597e-41ae-b5bf-323ed5d45dc8 600 Mari, Zoltan 50d5093d-ad2a-4e1f-8f95-15c32234670f 600 Cubo Delgado, Esther 131 600 0000-0003-0018-1182 2026-05-12T06:27:25Z 2026-05-12T06:27:25Z 2026-02 2330-1619 https://hdl.handle.net/10259/11607 10.1002/mdc3.70314 2330-1619 Background: Overcoming existing access barriers is crucial for better-specialized health care ofpatients with Parkinson’s disease (PD).ObjectiveObjective: The aim of the study was to compare the access and visit quality/acceptability between in-office andvirtual telemedicine visits.MethodsMethods: This was an international, randomized, case-control, prospective, observational study. Patients wererandomly assigned either to the control group (in-person/in-office visits at baseline, 3, 6, 9, and 12 months) or tothe study group (in-office visits at baseline, 6, and 12 months, and telemedicine visits at 3 and 9 months).Telemedicine visits were conducted using videoconferencing apps that were readily accessible to the patient/caregivers. Outcomes were feasibility, usability, and the noninferiority of telemedicine compared to in-officevisits in PD patients regarding clinical progression and initiation of pharmacological/nonpharmacologicaltreatments over 1-year follow-up.ResultsResults: We included 209 PD patients from 6 countries (Nigeria, Spain, Saudi Arabia, South Korea, Egypt, andUruguay), mean age 64.9 12.2 years, 59% males, median Hoehn & Yahr stage 2 (1–4). Overall, diseaseprogression (MDS-Unified PD rating scale), quality of life (PD-Quality of life 39-items) scores, and therapeuticchanges were similar in both groups. After 1 year, 124 patients 48.3%, (control group) and 52.1% (study group)completed the visits (P = 0.52), with a similar high rate of patient’s satisfaction with the visits (P = 0.57).ConclusionsConclusions: This study represents real-world telemedicine practice in different world regions using atelemedicine approach complementary to in-person visits. Based on these results, feasibility, clinicalmanagement, PD disease progression, and patient’s quality of life are similar when using telemedicine versusin-office visits. Future research should explore ways to integrate different healthcare technologies for long-termPD management. Edmond J. Safra Philanthropic Foundation Open access funding provided by FEDER European Funds and the Junta De Castilla y León under the Research and Innovation Strategy for Smart Specialization (RIS3) of Castilla y León 2021-2027 application/pdf eng Wiley Movement Disorders Clinical Practice. 2026, V. 13, n. 2, p. 419-429 https://doi.org/10.1002/mdc3.70314 Attribution-NonCommercial-NoDerivatives 4.0 Internacional http://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccess Telemedicine Parkinson's disease Multidisciplinary team Telemedicina Enfermedad de Parkinson Telecommunication in medicine Parkinson's disease The Feasibility and Practical Utility of Virtual Visits for Patients with Parkinson's Disease in Different World Regions info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Movement Disorders Clinical Practice 13 2 419 429 https://ror.org/051jb1k20 Consorcio de Bibliotecas Universitarias de Castilla y León (BUCLE) hybrid-oa 1 2488,66 EUR 9100199480 John Wiley & Sons 2025-04-30 2025-11-14 2025-01-01 2028-12-31 10.1002/mdc3.70314 THUMBNAIL Garcia-mdcp_2026.pdf.jpg Garcia-mdcp_2026.pdf.jpg IM Thumbnail image/jpeg 5066 https://riubu.ubu.es/bitstream/10259/11607/4/Garcia-mdcp_2026.pdf.jpg de50008b18deb5850f7163c5b07785e6 MD5 4 LICENSE license.txt license.txt text/plain; charset=utf-8 999 https://riubu.ubu.es/bitstream/10259/11607/3/license.txt b295bcbce42e2caabeb0c623d3860c06 MD5 3 CC-LICENSE license_rdf license_rdf application/rdf+xml; charset=utf-8 805 https://riubu.ubu.es/bitstream/10259/11607/2/license_rdf 4460e5956bc1d1639be9ae6146a50347 MD5 2 ORIGINAL Garcia-mdcp_2026.pdf Garcia-mdcp_2026.pdf application/pdf 615935 https://riubu.ubu.es/bitstream/10259/11607/1/Garcia-mdcp_2026.pdf 1f1d4ffdde3aaf04b8ff93d208417317 MD5 1 10259/11607 oai:riubu.ubu.es:10259/11607 2026-05-15 13:45:27.44 Repositorio Institucional de la Universidad de Burgos bubrep@ubu.es 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